Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
29 July 2011

IN THIS ISSUE
BMS and Amira
Improving leaflets
FDA report
Flu vaccines

BMS to acquire Amira for $325 Million
Bristol-Myers Squibb (BMS) has signed an agreement to acquire Amira Pharmaceuticals, a small-molecule company with a focus on treatments for inflammatory and fibrotic diseases, for $325 million. More...
 
EMA improves the readability of packaging leaflets
The European Medicines Agency has updated the template for package leaflets to make the information easier for patients to understand. More...
 
FDA identifies key regulatory needs and strategies
The FDA has released a report from its Center for Drug Evaluation and Research (CDER) that identifies regulatory science needs that will guide CDER’s strategic planning in the years ahead and allow it to fulfill its regulatory mission. More...
 
Flu vaccine production will double by 2015
The global production of seasonal influenza vaccine will double to 1.7 billion doses by 2015, according to presentation given by Marie-Paule Kieny, the World Health Organization’s (WHO) assistant director general for innovation, information, evidence and research. More...
 
Foreign scientists welcome, sort of
The national policies of some countries may be acting as a barrier to the entry of foreign scientists, according to a report by ScienceInsider. More...
 
Join our community on LinkedIn
Want to discuss any of this week's news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More...
 

Latest blog posts
Debt ceiling and debt reduction: an unwelcomed Rx for pharma
Drugmakers, uncle Sam wants you to help reduce spending
A breath of flu air
More blog posts

Latest articles
Degradation and what it means to the supply chain
Achieving lean processing with single-use systems
Overcoming common lyophilisation scale up issues
More latest articles

Upcoming events
World Drug Delivery Congress (5–7 September | Singapore)
Advances in Pharmaceutical Process Design (6–8 September | Ireland)
European Chemicals Policy — REACH (7–8 September | Spain)
More events

Product/Service Profiles
Patheon

Protect Your Supply with Patheon
Regulatory agencies are escalating the pressure on outsourced sterile manufacturing. Establishing a back-up solution with Patheon is like having an insurance policy for your sterile product supply.Read more

 
Shimadzu

The Nexera MP UHPLC for LC/MS analysis in drug detection processes
Shimadzu has introduced the Nexera MP UHPLC as a Front End system for LC/MS. The Nexera MP is perfect for LC/MS analysis conducted in pharmacokinetics and synthesis stages in drug detection processes.Read more

 
Sterilin

Superior quality pipettes for endotoxin testing
Sterilin single-use, serological pipettes are certified non-pyrogenic to a lower level than ever before (0.01EU/ml), making them ideal for pharmaceutical and medical device manufacturers to use when ensuring that their products are free from endotoxin contamination.Read more

 
Veltek

Veltek debuts new sterile clean room wipes, including the industry's first sodium hypochlorite and hydrogen peroxide clean room wipes.
Veltek Associates, Inc., recently debuted four new sterile clean room wipes, including the HYPO-CHLOR® Saturated Sodium Hypochlorite Wipe and the STERI-PEROX®. Saturated Hydrogen Peroxide Wipe.Read more


Event profile

Extractables & Leachables for Pharmaceutical Products
27-28 September 2011
Dublin, Ireland
Extractables and leachables assessment of all materials - especially from elastomeric and plastic components - forms an integral part of the submission for approval of a new drug system or medical device.Read more

Survey
How important will biosimilars be in the future?
Extremely important. They will dominate biopharmaceutical sales within the next five years   52%
     
Somewhat important, but probably less dominant than people now think   44%
     
Not at all important. It's just the current bandwagon   4%

This week we would like to know

Does the increasing demand for highly potent APIs justify the high costs associated with upgrading manufacturing containment systems?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK.